Cite
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
MLA
Juan Chen, et al. “Plasma Metabolomics of Immune-Related Adverse Events for Patients with Lung Cancer Treated with PD-1/PD-L1 Inhibitors.” Journal for ImmunoTherapy of Cancer, vol. 12, no. 7, July 2024. EBSCOhost, https://doi.org/10.1136/jitc-2024-009399.
APA
Juan Chen, Jun-yan Liu, Fan Yang, Ting Zou, Zhan Wang, Jia-Si Liu, Lei She, Xiang-Ping Li, & Zhaoqian Liu. (2024). Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors. Journal for ImmunoTherapy of Cancer, 12(7). https://doi.org/10.1136/jitc-2024-009399
Chicago
Juan Chen, Jun-yan Liu, Fan Yang, Ting Zou, Zhan Wang, Jia-Si Liu, Lei She, Xiang-Ping Li, and Zhaoqian Liu. 2024. “Plasma Metabolomics of Immune-Related Adverse Events for Patients with Lung Cancer Treated with PD-1/PD-L1 Inhibitors.” Journal for ImmunoTherapy of Cancer 12 (7). doi:10.1136/jitc-2024-009399.